Recombinant factor VIIa (rFVIIa) clinical trials

Treatment of Hemophilia A Patients With FVIII Inhibitors

This study looks at how doctors manage Haemophilia A in men who develop ‘inhibitors’ to their treatment. It observes different treatments, including a new medicine called emicizumab, to see how well they work and if they are safe over up to five years.